Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Galapagos NV
  6. News
  7. Summary
    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Galapagos : GLPG3667 Shows Positive Results in Psoriasis Patients, Reports Topline Results for GLPG3970 in Three Studies

07/14/2021 | 04:36pm EDT


ę MT Newswires 2021
All news about GALAPAGOS NV
09/21GALAPAGOS : increases share capital through subscription right exercises (Form 6-K)
PU
09/21GALAPAGOS : N.V., - Galapagos increases share capital through subscription right exercises
PU
09/21GALAPAGOS : Issues New Shares For Subscription Right Exercises
MT
09/20GALAPAGOS : increases share capital through subscription right exercises
AQ
09/20GALAPAGOS : ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA« (FILGOTINIB) FOR THE TREATMENT O..
PU
09/17GALAPAGOS : N.v., - galapagos announces positive chmp opinion for jyseleca« (filgotinib) f..
PU
09/17GALAPAGOS : Gets European Medicines Agency's Positive Opinion on Ulcerative Colitis Drug C..
MT
09/17GALAPAGOS : Says it Received European Medicines Agency Positive Opinion for Ulcerative Col..
MT
09/17GALAPAGOS : Announces positive chmp opinion for jyseleca« (filgotinib) for the treatment o..
AQ
09/17Galapagos Announces Positive CHMP Opinion for Jyseleca« for the Treatment of Adults wit..
CI
More news
Analyst Recommendations on GALAPAGOS NV
More recommendations
Financials
Sales 2021 519 M 608 M 608 M
Net income 2021 -224 M -262 M -262 M
Net cash 2021 3 243 M 3 797 M 3 797 M
P/E ratio 2021 -15,1x
Yield 2021 -
Capitalization 3 014 M 3 530 M 3 530 M
EV / Sales 2021 -0,44x
EV / Sales 2022 -0,32x
Nbr of Employees 1 397
Free-Float 73,8%
Chart GALAPAGOS NV
Duration : Period :
Galapagos NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GALAPAGOS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 46,00 €
Average target price 59,71 €
Spread / Average Target 29,8%
EPS Revisions
Managers and Directors
Onno van de Stolpe Chief Executive Officer
Bart Filius President & Chief Operating Officer
Raj B. Parekh Chairman
Piet Wigerinck Chief Scientific Officer
Walid Abi-Saab Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GALAPAGOS NV-42.84%3 538
MODERNA, INC.335.15%183 498
LONZA GROUP AG33.58%61 085
IQVIA HOLDINGS INC.46.38%50 254
CELLTRION, INC.-20.75%33 124
SEAGEN INC.-5.09%30 241